Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing ; volume:79 ; number:12 ; day:21 ; month:10 ; year:2023 ; pages:1709-1711 ; date:12.2023
European journal of clinical pharmacology ; 79, Heft 12 (21.10.2023), 1709-1711, 12.2023
- Urheber
-
Härkänen, Lasse
Hakomäki, Henriikka
Huopio, Jukka
Kokki, Hannu
Korhonen, Sanni
Lehtonen, Marko
Sjövall, Sari
Kokki, Merja
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-023-03583-4
- URN
-
urn:nbn:de:101:1-2024020907591537472930
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Härkänen, Lasse
- Hakomäki, Henriikka
- Huopio, Jukka
- Kokki, Hannu
- Korhonen, Sanni
- Lehtonen, Marko
- Sjövall, Sari
- Kokki, Merja
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Transdermal buprenorphine in cancer pain and palliative care
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Transdermal electroosmotic flow generated by a porous microneedle array patch
Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Transdermal buprenorphine in cancer pain and palliative care
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Transdermal electroosmotic flow generated by a porous microneedle array patch
Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Transdermal buprenorphine in cancer pain and palliative care
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Transdermal electroosmotic flow generated by a porous microneedle array patch